The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program
David T. Rubin, Charlie W. Lees, Filip Baert, Maria Kudela et autres
us, gb, be, in, ch, ca (code pays fourni par la source)